Morgan Stanley
GOCO

Morgan Stanley’s GoHealth GOCO Stock Holding History

Morgan Stanley’s Portfolio GOCO Stock Details GOCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,786
Closed -$38.9K – 8491
2026
Q1 		$38.9K Buy
25,786
+4,922
+24% +$9.4K ﹤0.01% 6510
2025
Q4 		$44.9K Sell
20,864
-897
-4% -$3.06K ﹤0.01% 6472
2025
Q3 		$105K Sell
21,761
-2,065
-9% -$11.3K ﹤0.01% 6126
2025
Q2 		$132K Sell
23,826
-41,092
-63% -$325K ﹤0.01% 6028
2025
Q1 		$797K Buy
64,918
+13,622
+27% +$208K ﹤0.01% 5113
2024
Q4 		$687K Buy
51,296
+4,879
+11% +$55.5K ﹤0.01% 5285
2024
Q3 		$435K Buy
46,417
+7,788
+20% +$78.8K ﹤0.01% 5465
2024
Q2 		$375K Sell
38,629
-1,727
-4% -$17.1K ﹤0.01% 5422
2024
Q1 		$424K Sell
40,356
-4,242
-10% -$52.4K ﹤0.01% 5387
2023
Q4 		$595K Buy
44,598
+8,509
+24% +$116K ﹤0.01% 5219
2023
Q3 		$523K Sell
36,089
-4,509
-11% -$77.6K ﹤0.01% 5147
2023
Q2 		$800K Sell
40,598
-17,443
-30% -$274K ﹤0.01% 4962
2023
Q1 		$945K Sell
58,041
-3,806
-6% -$58.8K ﹤0.01% 4896
2022
Q4 		$646K Buy
61,847
+24,599
+66% +$218K ﹤0.01% 5104
2022
Q3 		$199K Sell
37,248
-3,796
-9% -$28.6K ﹤0.01% 5729
2022
Q2 		$367K Sell
41,044
-34,804
-46% -$405K ﹤0.01% 5578
2022
Q1 		$1.34M Sell
75,848
-80,559
-52% -$2.51M ﹤0.01% 4793
2021
Q4 		$8.89M Buy
156,407
+87,894
+128% +$5.87M ﹤0.01% 3071
2021
Q3 		$5.17M Buy
68,513
+26,524
+63% +$2.81M ﹤0.01% 3654
2021
Q2 		$7.06M Buy
41,989
+28,767
+218% +$5.04M ﹤0.01% 3408
2021
Q1 		$2.32M Buy
13,222
+2,342
+22% +$472K ﹤0.01% 4135
2020
Q4 		$2.23M Buy
10,880
+5,463
+101% +$1.01M ﹤0.01% 4054
2020
Q3 		$1.06M Buy
+5,417
New +$1.3M ﹤0.01% 4179

Other funds holding GOCO

Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $19B AUM 51.73% 1-Year Est. Return
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.5B AUM 19.48% 1-Year Est. Return
GBT
Grove Bank & Trust Miami, Florida $1.01B AUM 26.88% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Morgan Stanley's GOCO Position: Q2 2026 in Review

Morgan Stanley sold out of GoHealth (GOCO) in Q2 2026, closing a stake of 25,786 shares — an estimated $38.9K sold.

Morgan Stanley first reported a position in GOCO in Q3 2020 and held it in 23 quarters. The position peaked at $8.89M in Q4 2021. 5 funds tracked by Wall St. Rank hold GOCO as of Q2 2026.

  • Morgan Stanley reported no remaining GoHealth position as of Q2 2026 after selling out during the quarter.
  • Morgan Stanley sold 25,786 GoHealth shares in Q2 2026, an estimated $38.9K.
  • Morgan Stanley first reported a position in GoHealth in Q3 2020 and held it in 23 quarters.
  • Morgan Stanley's GoHealth position peaked at $8.89M in Q4 2021.
  • 5 funds tracked by Wall St. Rank held GoHealth as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.